These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10961808)

  • 1. CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer.
    Pandit R; Lathers DM; Beal NM; Garrity T; Young MR
    Ann Otol Rhinol Laryngol; 2000 Aug; 109(8 Pt 1):749-54. PubMed ID: 10961808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck squamous cell carcinomas and the ability of these CD34+ cells to differentiate into immune stimulatory dendritic cells.
    Lathers DM; Achille N; Kolesiak K; Hulett K; Sparano A; Petruzzelli GJ; Young MR
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):205-12. PubMed ID: 11555755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells.
    Garrity T; Pandit R; Wright MA; Benefield J; Keni S; Young MR
    Int J Cancer; 1997 Nov; 73(5):663-9. PubMed ID: 9398043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cultures derived from peripheral blood CD34+ progenitor cells of head and neck cancer patients and from cord blood are functionally different.
    Lathers DM; Lubbers E; Beal NM; Wright MA; Young MR
    Hum Immunol; 1999 Dec; 60(12):1207-15. PubMed ID: 10626734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell differentiation pathways of CD34+ cells from the peripheral blood of head and neck cancer patients.
    Lathers DM; Lubbers E; Wright MA; Young MR
    J Leukoc Biol; 1999 May; 65(5):623-8. PubMed ID: 10331490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.
    Pak AS; Wright MA; Matthews JP; Collins SL; Petruzzelli GJ; Young MR
    Clin Cancer Res; 1995 Jan; 1(1):95-103. PubMed ID: 9815891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34+ cells within human head and neck squamous cell carcinomas.
    Young MR; Wright MA; Pandit R
    J Immunol; 1997 Jul; 159(2):990-6. PubMed ID: 9218621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase IB study of 25-hydroxyvitamin D(3) treatment to diminish suppressor cells in head and neck cancer patients.
    Lathers DM; Clark JI; Achille NJ; Young MR
    Hum Immunol; 2001 Nov; 62(11):1282-93. PubMed ID: 11704292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective mechanisms of head and neck squamous cell carcinomas from immune assault.
    Young MR
    Head Neck; 2006 May; 28(5):462-70. PubMed ID: 16284974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of circulating natural killer cells and T lymphocytes in head and neck squamous cell carcinoma.
    Böttcher A; Ostwald J; Guder E; Pau HW; Kramp B; Dommerich S
    Auris Nasus Larynx; 2013 Apr; 40(2):216-21. PubMed ID: 22835730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood.
    Nitsch SM; Pries R; Wollenberg B
    In Vivo; 2007; 21(3):493-8. PubMed ID: 17591359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers.
    Young MR; Lathers DM
    Int J Immunopharmacol; 1999 Apr; 21(4):241-52. PubMed ID: 10408632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis.
    Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD
    Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cycling CD34 expression in subpopulations of head and neck squamous cell carcinoma cell lines is involved in radioresistance and change in cytokeratin expression profile.
    Ettl T; Hautmann M; Reichert TE; Bauer R
    Clin Exp Med; 2017 Nov; 17(4):565-574. PubMed ID: 27837456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3.
    Lathers DM; Clark JI; Achille NJ; Young MR
    Cancer Immunol Immunother; 2004 May; 53(5):422-30. PubMed ID: 14648070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34(+) progenitor cells.
    Young MR; Petruzzelli GJ; Kolesiak K; Achille N; Lathers DM; Gabrilovich DI
    Hum Immunol; 2001 Apr; 62(4):332-41. PubMed ID: 11295465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like Receptors in Regulatory T Cells of Patients With Head and Neck Cancer.
    Wild CA; Brandau S; Lindemann M; Lotfi R; Hoffmann TK; Lang S; Bergmann C
    Arch Otolaryngol Head Neck Surg; 2010 Dec; 136(12):1253-9. PubMed ID: 21173376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis.
    Aarstad HJ; Heimdal JH; Klementsen B; Olofsson J; Ulvestad E
    Acta Otolaryngol; 2006 Dec; 126(12):1326-33. PubMed ID: 17101596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total lymphocyte and T lymphocyte subpopulation levels in head and neck squamous cell carcinomas.
    Soysal V; Yigitbasi OG; Alper M; Patiroglu T; Güney E
    J Exp Clin Cancer Res; 1998 Jun; 17(2):207-12. PubMed ID: 9700582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.